Evaluation of the effect of oral acetaminophen on the treatment of neonatal PDAs
Phase 2
Recruiting
- Conditions
- Patent ductus arteriosus.Patent ductus arteriosus
- Registration Number
- IRCT20170801035441N1
- Lead Sponsor
- Esfahan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
All neonate with 32 weeks or less requiring PDA treatment for clinical conditions
PDA is confirmed by echocardiography
Age less than 14 days
Exclusion Criteria
Congenital heart disease
Clinical and laboratory symptoms of sepsis
Chromosomal or congenital abnormalities
The presence of Ibuprofen is contraindicated
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The closure rate of patent ductus arteriosus (PDA). Timepoint: Echocardiography at the beginning of the study and then 48-72 hours after treatment. Method of measurement: Confirmed by echocardiography.
- Secondary Outcome Measures
Name Time Method